Evaluation and Treatment of Menorrhagia in an Adolescent Population

Journal of Minimally Invasive Gynecology

Volumn 15, Issue 6, 2008, Pages 682-688

  Frishman, Gary N ^a  

^a WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

Adolescent; Dysfunctional uterine bleeding; Menorrhagia; Teenager

Indexed keywords

ETHINYLESTRADIOL; GESTAGEN; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT; TRANEXAMIC ACID;

ANOVULATION; HEALTH SURVEY; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LONG TERM CARE; MEDICAL RESEARCH; MENORRHAGIA; PHYSICAL EXAMINATION; REVIEW; TREATMENT OUTCOME; UTERUS BLEEDING;

ADOLESCENT; ANOVULATION; BODY MASS INDEX; CONTRACEPTIVES, ORAL, HORMONAL; FEAR; FEMALE; HUMANS; INTRAUTERINE DEVICES; MENORRHAGIA; PATIENT CARE PLANNING; PHYSICAL EXAMINATION; RETROSPECTIVE STUDIES;

EID: 54349116467     PISSN: 15534650     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmig.2008.08.014     Document Type: Review

References (45)

1. Friberg B., Orno A.K., Lindgren A., and Lethagen S. Bleeding disorders among young women: a population-based prevalence study. Acta Obstet Gynecol Scand 85 (2006) 200-206
2. Hallberg L., Hogdahl A.M., Nilsson L., and Rybo G. Menstrual blood loss and iron deficiency. Acta Med Scand 180 (1966) 639-650
3. Strickland J.L., and Wall J.W. Abnormal uterine bleeding in adolescents. Obstet Gynecol Clin North Am 30 (2003) 321-335
4. American College of Obstetricians and Gynecologists committee opinion No. 349, November 2006. Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Obstet Gynecol 108 (2006) 1323-1328
5. Philipp C.S., Faiz A., Dowling N., et al. Age and the prevalence of bleeding disorders in women with menorrhagia. Obstet Gynecol 105 (2005) 61-66
6. Pawar A., Krishnan R., Davis K., Bosma K., and Kulkarni R. Perceptions about quality of life in a school-based population of adolescents with menorrhagia: implications for adolescents with bleeding disorders. Haemophilia 14 (2008) 579-583
7. Fraser I.S., Critchley H.O., Munro M.G., and Broder M. Can we achieve international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding?. Hum Reprod 22 (2007) 635-643
8. Quint E.H., and Smith Y.R. Abnormal uterine bleeding in adolescents. J Midwifery Womens Health 48 (2003) 186-191
9. Dilley A., Drews C., Miller C., et al. Von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia. Obstet Gynecol 97 (2001) 630-636
10. Claessens E.A., and Cowell C.A. Acute adolescent menorrhagia. Am J Obstet Gynecol 139 (1981) 277-280
11. Kouides P.A. Menorrhagia from a hematologist's point of view, part I: initial evaluation. Haemophilia 8 (2002) 330-338
12. Castaman G., Federici A.B., Rodeghiero F., and Mannucci P.M. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment. Haematologica 88 (2003) 94-108
13. Adams Hillard P.J. Menstruation in young girls: a clinical perspective. Obstet Gynecol 99 (2002) 655-662
14. Alan Guttmacher Institute. Facts on American teens' sexual and reproductive health. Available from: http://www.guttmacher.org/pubs/fb_ATSRH.pdf.
15. Stat bite: HPV prevalence among sexually active females. J Natl Cancer Inst 99 (2007) 1575
16. Farhi D.C., Nosanchuk J., and Silverberg S.G. Endometrial adenocarcinoma in women under 25 years of age. Obstet Gynecol 68 (1986) 741-745
17. American College of Obstetricians and Gynecologists practice bulletin: management of anovulatory bleeding. Int J Gynaecol Obstet 72 (2001) 263-271
18. Bulas D.I., Ahlstrom P.A., Sivit C.J., Blask A.R., and O'Donnell R.M. Pelvic inflammatory disease in the adolescent: comparison of transabdominal and transvaginal sonographic evaluation. Radiology 183 (1992) 435-439
19. Falcone T., Desjardins C., Bourque J., Granger L., Hemmings R., and Quiros E. Dysfunctional uterine bleeding in adolescents. J Reprod Med 39 (1994) 761-764
20. Janssen C.A., Scholten P.C., and Heintz A.P. A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss. Obstet Gynecol 85 (1995) 977-982
21. Barr F., Brabin L., and Agbaje O. A pictorial chart for managing common menstrual disorders in Nigerian adolescents. Int J Gynaecol Obstet 66 (1999) 51-53
22. Munro M.G., Mainor N., Basu R., Brisinger M., and Barreda L. Oral medroxyprogesterone acetate and combination oral contraceptives for acute uterine bleeding: a randomized controlled trial. Obstet Gynecol 108 (2006) 924-929
23. DeVore G.R., Owens O., and Kase N. Use of intravenous Premarin in the treatment of dysfunctional uterine bleeding-a double-blind randomized control study. Obstet Gynecol 59 (1982) 285-291
24. McCall R.E., and Bilderback K.K. Use of intravenous Premarin to decrease postoperative blood loss after pediatric scoliosis surgery. Spine 22 (1997) 1394-1397
25. Gerschultz K.L., Sucato G.S., Hennon T.R., Murray P.J., and Gold M.A. Extended cycling of combined hormonal contraceptives in adolescents: physician views and prescribing practices. J Adolesc Health 40 (2007) 151-157
26. Bagwell M.A., Thompson S.J., Addy C.L., Coker A.L., and Baker E.R. Primary infertility and oral contraceptive steroid use. Fertil Steril 63 (1995) 1161-1166
27. Lethaby A., Irvine G., and Cameron I. Cyclical progestogens for heavy menstrual bleeding. Cochrane Database Syst Rev 2 (2000) CD001016
28. Tsai W.S., Inge T.H., and Burd R.S. Bariatric surgery in adolescents: recent national trends in use and in-hospital outcome. Arch Pediatr Adolesc Med 161 (2007) 217-221
29. van Eijkeren M.A., Christiaens G.C., Scholten P.C., and Sixma J.J. Menorrhagia: current drug treatment concepts. Drugs 43 (1992) 201-209
30. Lethaby A., Augood C., and Duckitt K. Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev 1 (2002) CD000400
31. Food and Drug Administration. Available from: http://www.fda.gov/medwatch/safety/2008/May_PI/Mirena_PI.pdf.
32. American College of Obstetricians and Gynecologists committee opinion No. 392, December 2007. Intrauterine device and adolescents. Obstet Gynecol 110 (2007) 1493-1495
33. Marjoribanks J., Lethaby A., and Farquhar C. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev 2 (2006) CD003855
34. Kingman C.E., Kadir R.A., Lee C.A., and Economides D.L. The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders. BJOG 111 (2004) 1425-1428
35. Kasonde J.M., and Bonnar J. Aminocaproic acid and menstrual loss in women using intrauterine devices. Br Med J 4 (1975) 17-19
36. Mercorio F., De Simone R., Di Carlo C., et al. Effectiveness and mechanism of action of desmopressin in the treatment of copper intrauterine device-related menorrhagia: a pilot study. Hum Reprod 18 (2003) 2319-2322
37. Edlund M., Blomback M., and Fried G. Desmopressin in the treatment of menorrhagia in women with no common coagulation factor deficiency but with prolonged bleeding time. Blood Coagul Fibrinolysis 13 (2002) 225-231
38. Meirow D., Rabinovici J., Katz D., Or R., Shufaro Y., and Ben-Yehuda D. Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate. Cancer 107 (2006) 1634-1641
39. Divasta A.D., Laufer M.R., and Gordon C.M. Bone density in adolescents treated with a GnRH agonist and add-back therapy for endometriosis. J Pediatr Adolesc Gynecol 20 (2007) 293-297
40. van der Sluis I.M., Boot A.M., Krenning E.P., and Drop S.L. de Muinck Keizer-Schrama SM. Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during and after cessation of GnRH agonist therapy. J Clin Endocrinol Metab 87 (2002) 506-512
41. Gafni R.I., and Baron J. Overdiagnosis of osteoporosis in children due to misinterpretation of dual-energy x-ray absorptiometry (DEXA). J Pediatr 144 (2004) 253-257
42. Bowkley C.W., Dubel G.J., Haas R.A., Soares G.M., and Ahn S.H. Uterine artery embolization for control of life-threatening hemorrhage at menarche: brief report. J Vasc Interv Radiol 18 (2007) 127-131
43. Pron G., Mocarski E., Bennett J., Vilos G., Common A., and Vanderburgh L. Pregnancy after uterine artery embolization for leiomyomata: the Ontario multicenter trial. Obstet Gynecol 105 (2005) 67-76
44. Zurawin R.K., and Pramanik S. Endometrial balloon ablation as a therapy for intractable uterine bleeding in an adolescent. J Pediatr Adolesc Gynecol 14 (2001) 119-121
45. Grover S.R. Menstrual and contraceptive management in women with an intellectual disability. Med J Aust 176 (2002) 108-110